首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study.
【24h】

Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study.

机译:在REGARDS(中风的地理和种族差异原因)研究中,肾功能,白蛋白尿和全因死亡率。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Chronic kidney disease and albuminuria are associated with increased risk of all-cause mortality. STUDY DESIGN: Prospective observational cohort study. SETTING & PARTICIPANTS: 17,393 participants (mean age, 64.3 +/- 9.6 years) in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. PREDICTOR: Estimated glomerular filtration rate (eGFR), urinary albumin-creatinine ratio (ACR). OUTCOME: All-cause mortality (710 deaths); median duration of follow-up, 3.6 years. MEASUREMENTS & ANALYSIS: Categories of eGFR (90 to <120, 60 to <90, 45 to <60, 30 to <45, and 15 to <30 mL/min/1.73 m(2)) and urinary ACR (<10 mg/g or normal, 10 to <30 mg/g or high normal, 30 to 300 mg/g or high, and >300 mg/g or very high). Cox proportional hazards models were adjusted for demographic factors, cardiovascular covariates, and hemoglobin level. RESULTS: The background all-cause mortality rate for participants with normal ACR, eGFR of 90 to <120 mL/min/1.73 m(2), and no coronary heart disease was 4.3 deaths/1,000 person-years. Higher ACR was associated with an increased multivariable-adjusted HR for all-cause mortality within each eGFR category. Decreased eGFR was associated with a higher adjusted HR for all-cause mortality for participants with high-normal (P = 0.01) and high (P < 0.001) ACRs, but not those with normal or very high ACRs. LIMITATIONS: Only 1 laboratory assessment for serum creatinine and ACR was available. CONCLUSIONS: Increased albuminuria was an independent risk factor for all-cause mortality. Decreased eGFR was associated with increased mortality risk in those with high-normal and high ACRs. The mortality rate was low in the normal-ACR group and increased in the very-high-ACR group, but did not vary with eGFR in these groups.
机译:背景:慢性肾脏疾病和蛋白尿与全因死亡风险增加有关。研究设计:前瞻性观察队列研究。地点和参加者:REGARDS(卒中地理和种族差异的原因)研究的17,393名参与者(平均年龄,64.3 +/- 9.6岁)。预测:估计的肾小球滤过率(eGFR),尿白蛋白-肌酐比值(ACR)。结果:全因死亡率(710例死亡);中位随访时间3.6年。测量与分析:eGFR的类别(90至<120、60至<90、45至<60、30至<45和15至<30 mL / min / 1.73 m(2))和尿液ACR(<10 mg / g或正常,10至<30 mg / g或高正常,30至300 mg / g或高,> 300 mg / g或非常高)。对Cox比例风险模型进行了人口统计学因素,心血管协变量和血红蛋白水平的调整。结果:正常ACR,eGFR为90至<120 mL / min / 1.73 m(2),无冠心病的参与者的背景全因死亡率为每1000人年4.3例死亡。较高的ACR与每个eGFR类别内全因死亡率的多变量调整后HR升高相关。 eGFR降低与高ACR(P = 0.01)和ACR高(P <0.001)参与者的全因死亡率校正后的HR升高相关,而与ACR正常或非常高的参与者无关。局限性:仅有1项血清肌酐和ACR的实验室评估可用。结论:白蛋白尿增加是全因死亡率的独立危险因素。 eGFR降低与高ACR和高ACR的患者死亡风险增加相关。正常ACR组的死亡率很低,而ACR很高的组死亡率却有所增加,但是这些eGFR组的死亡率没有变化。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号